Whittier Trust’s CytomX Therapeutics CTMX Stock Holding History

Whittier Trust’s Portfolio CTMX Stock Details CTMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.7K	Buy	+11,458	New	+$43.7K	﹤0.01%	890
2024 Q3	–	Sell	-2,200	Closed	-$2.68K	–	1552
2024 Q2	$2.68K	Sell	2,200 -4,404	-67%	-$8.77K	﹤0.01%	1406
2024 Q1	$14.4K	Hold	6,604	–	–	﹤0.01%	1204
2023 Q4	$10.2K	Hold	6,604	–	–	﹤0.01%	1233
2023 Q3	$8.45K	Sell	6,604 -1,759	-21%	-$2.77K	﹤0.01%	1298
2023 Q2	$14.4K	Hold	8,363	–	–	﹤0.01%	1193
2023 Q1	$12.5K	Hold	8,363	–	–	﹤0.01%	1255
2022 Q4	$13.3K	Hold	8,363	–	–	﹤0.01%	1236
2022 Q3	$12K	Hold	8,363	–	–	﹤0.01%	1302
2022 Q2	$15K	Sell	8,363 -2,645	-24%	-$5.06K	﹤0.01%	1240
2022 Q1	$29K	Hold	11,008	–	–	﹤0.01%	1106
2021 Q4	$48K	Hold	11,008	–	–	﹤0.01%	982
2021 Q3	$56K	Hold	11,008	–	–	﹤0.01%	904
2021 Q2	$70K	Hold	11,008	–	–	﹤0.01%	871
2021 Q1	$85K	Hold	11,008	–	–	﹤0.01%	812
2020 Q4	$72K	Hold	11,008	–	–	﹤0.01%	776
2020 Q3	$73K	Hold	11,008	–	–	﹤0.01%	758
2020 Q2	$92K	Hold	11,008	–	–	﹤0.01%	690
2020 Q1	$84K	Hold	11,008	–	–	﹤0.01%	695
2019 Q4	$91K	Hold	11,008	–	–	﹤0.01%	718
2019 Q3	$81K	Hold	11,008	–	–	﹤0.01%	734
2019 Q2	$124K	Hold	11,008	–	–	﹤0.01%	615
2019 Q1	$118K	Hold	11,008	–	–	﹤0.01%	622
2018 Q4	$166K	Hold	11,008	–	–	0.01%	541
2018 Q3	$204K	Sell	11,008 -2,205	-17%	-$50.2K	0.01%	512
2018 Q2	$302K	Hold	13,213	–	–	0.01%	439
2018 Q1	$376K	Buy	+13,213	New	+$377K	0.01%	413

Other funds holding CTMX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Whittier Trust's CTMX Position: Q2 2026 in Review

Whittier Trust opened a new position in CytomX Therapeutics (CTMX) in Q2 2026: 11,458 shares worth $43.7K. The stake represents ﹤0.01% of the portfolio and ranks #890 among its holdings. This is a return to the name: Whittier Trust previously reported a position in CTMX as recently as Q2 2024.

Whittier Trust first reported a position in CTMX in Q1 2018 and has held it in 27 quarters since. The position peaked at $376K in Q1 2018. 179 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

Whittier Trust held 11,458 shares of CytomX Therapeutics worth $43.7K as of Q2 2026.
CytomX Therapeutics was a new Whittier Trust position in Q2 2026.
CytomX Therapeutics made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #890 holding.
Whittier Trust first reported a position in CytomX Therapeutics in Q1 2018 and has held it in 27 quarters since.
Whittier Trust's CytomX Therapeutics position peaked at $376K in Q1 2018.
179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.